Ratification Date: 21/07/2025

Next Review Date: 21/07/2027

Eptifibatide – Prevention of MI in unstable angina – as per NICE TA 47

Drug Name (Brand) Eptifibatide  (Integrilin®)
Indication Prevention of MI in unstable angina – as per NICE TA 47
Traffic Light Classification Red
NICE TA (plus link) Overview | Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes | Guidance | NICE
Further Information:

NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.

 

NICE TA 47 (last update March 2010): For high-risk patients with unstable angina or non-Q-wave myocardial infarction the intravenous use of the glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors (consistent with current UK licensing), in addition to aspirin and low (adjusted) dose unfractionated heparin, is recommended.

Date of TAG recommendation / ratification  March 2010 Review Date